Radiomics in breast cancer: Current advances and future directions
Ying-Jia Qi(Fudan University Shanghai Cancer Center), Zhi‐Ming Shao(Shanghai Medical College of Fudan University), Chao You(Fudan University Shanghai Cancer Center), Yi Xiao(Fudan University Shanghai Cancer Center), Xu Zhang(Fudan University Shanghai Cancer Center), Yi-Zhou Jiang(Shanghai Medical College of Fudan University), Guan-Hua Su(Fudan University Shanghai Cancer Center)
Cited by 143
Related Papers
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
|Cell Research|2022|315
Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression
|Cancer Communications|2022|203
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
|Signal Transduction and Targeted Therapy|2024|187
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
|Signal Transduction and Targeted Therapy|2021|171